Key details
Phase
Safety & dosing / Large-scale testing
Sponsor
Hospital Authority, Hong Kong
Enrollment target
~20 participants
Primary completion
June 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years – 85 Years
Last updated December 2024